21 . 03 .2024
Press release
Galderma prices IPO at CHF 53 per share and will start trading on the SIX Swiss Exchange tomorrow
19 . 03 .2024
Press release
AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio
13 . 03 .2024
Press release
Galderma launches IPO on the SIX Swiss Exchange and sets price range
13 . 03 .2024
News story
Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma
10 . 03 .2024
Press release
Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis
